Aviva’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.6M Buy
100,538
+525
+0.5% +$197K 0.05% 298
2026
Q1
$28.1M Buy
100,013
+2,908
+3% +$844K 0.05% 325
2025
Q4
$28.7M Buy
97,105
+4,990
+5% +$1.5M 0.05% 321
2025
Q3
$22.6M Buy
92,115
+10,341
+13% +$2.08M 0.04% 347
2025
Q2
$12.8M Buy
81,774
+5,150
+7% +$547K 0.03% 470
2025
Q1
$6.05M Buy
+76,624
New +$8.13M 0.01% 521
2014
Q2
Sell
-320,000
Closed -$3.5M 827
2014
Q1
$3.5M Buy
+320,000
New +$3.18M 0.03% 572
2013
Q3
Sell
-306,778
Closed -$2.9M 838
2013
Q2
$2.9M Buy
+306,778
New +$2.7M 0.03% 498

Other funds holding CLS

Aviva's CLS Position: Q2 2026 in Review

Aviva increased its Celestica (CLS) stake by 0.52% in Q2 2026, buying an estimated $197K and bringing the position to 100,538 shares worth $36.6M. The position accounts for 0.05% of the portfolio, ranked #298.

Aviva first reported a position in CLS in Q2 2013 and has held it in 8 quarters since. 875 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Aviva held 100,538 shares of Celestica worth $36.6M as of Q2 2026.
  • Aviva bought 525 Celestica shares in Q2 2026, an estimated $197K.
  • Celestica made up 0.05% of Aviva's portfolio in Q2 2026, its #298 holding.
  • Aviva first reported a position in Celestica in Q2 2013 and has held it in 8 quarters since.
  • 875 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.